These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10226586)
1. Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines. al Moustafa AE; Alaoui-Jamali M; Paterson J; O'Connor-McCourt M Anticancer Res; 1999; 19(1A):481-6. PubMed ID: 10226586 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG; Ethier SP Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535 [TBL] [Abstract][Full Text] [Related]
4. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP; Kokeny KE; Ridings JW; Dilts CA Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031 [TBL] [Abstract][Full Text] [Related]
5. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis. Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604 [TBL] [Abstract][Full Text] [Related]
6. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells. Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Sepp-Lorenzino L; Eberhard I; Ma Z; Cho C; Serve H; Liu F; Rosen N; Lupu R Oncogene; 1996 Apr; 12(8):1679-87. PubMed ID: 8622888 [TBL] [Abstract][Full Text] [Related]
8. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. Ram TG; Kokeny KE; Dilts CA; Ethier SP J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601 [TBL] [Abstract][Full Text] [Related]
9. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304 [TBL] [Abstract][Full Text] [Related]
10. ErbB kinases and NDF signaling in human prostate cancer cells. Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997 [TBL] [Abstract][Full Text] [Related]
11. Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Gilbertson RJ; Clifford SC; MacMeekin W; Meekin W; Wright C; Perry RH; Kelly P; Pearson AD; Lunec J Cancer Res; 1998 Sep; 58(17):3932-41. PubMed ID: 9731505 [TBL] [Abstract][Full Text] [Related]
12. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895 [TBL] [Abstract][Full Text] [Related]
13. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. Ram TG; Hosick HL; Ethier SP J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu C; Tsao MS Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369 [TBL] [Abstract][Full Text] [Related]
15. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. Xu F; Yu Y; Le XF; Boyer C; Mills GB; Bast RC Clin Cancer Res; 1999 Nov; 5(11):3653-60. PubMed ID: 10589783 [TBL] [Abstract][Full Text] [Related]
16. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426 [TBL] [Abstract][Full Text] [Related]
17. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Marikovsky M; Lavi S; Pinkas-Kramarski R; Karunagaran D; Liu N; Wen D; Yarden Y Oncogene; 1995 Apr; 10(7):1403-11. PubMed ID: 7731691 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor expression in human lung cancer cell lines. Haeder M; Rotsch M; Bepler G; Hennig C; Havemann K; Heimann B; Moelling K Cancer Res; 1988 Mar; 48(5):1132-6. PubMed ID: 2830015 [TBL] [Abstract][Full Text] [Related]
19. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253 [TBL] [Abstract][Full Text] [Related]